The store will not work correctly when cookies are disabled.
3,5-dichloro-2-hydroxy-N-(3-methyl-4-phenoxy-phenyl)benzamide
ID: ALA4781027
PubChem CID: 162663636
Max Phase: Preclinical
Molecular Formula: C20H15Cl2NO3
Molecular Weight: 388.25
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(NC(=O)c2cc(Cl)cc(Cl)c2O)ccc1Oc1ccccc1
Standard InChI: InChI=1S/C20H15Cl2NO3/c1-12-9-14(7-8-18(12)26-15-5-3-2-4-6-15)23-20(25)16-10-13(21)11-17(22)19(16)24/h2-11,24H,1H3,(H,23,25)
Standard InChI Key: MNFXCIMOHFBBHM-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
28.6514 -12.7044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3597 -12.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3550 -11.4632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6459 -11.0598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0731 -12.6994 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.7834 -12.2839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4940 -12.6983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2037 -12.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2010 -11.4614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4826 -11.0557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7758 -11.4687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9107 -11.0491 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6246 -11.4540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3343 -11.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6289 -12.2753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.0426 -11.4488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7518 -11.0372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7480 -10.2150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0290 -9.8062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3269 -10.2242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6114 -9.8180 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.0219 -8.9849 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
36.4656 -11.4424 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.9360 -12.2912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9414 -11.4724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4943 -13.5155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 25 1 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
9 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
20 21 1 0
19 22 1 0
17 23 1 0
24 25 2 0
7 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 388.25 | Molecular Weight (Monoisotopic): 387.0429 | AlogP: 6.05 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.56 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.95 | CX Basic pKa: ┄ | CX LogP: 5.98 | CX LogD: 4.62 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.57 | Np Likeness Score: -1.29 |
References
1. Fujii S,Kikuchi E,Watanabe Y,Suzuyama H,Ishigami-Yuasa M,Mori T,Isobe K,Uchida S,Kagechika H. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling., 30 (17): [PMID:32738993] [10.1016/j.bmcl.2020.127408] |